Novel biomarker studies have shown that hyperphosphorylated Tau species exist in plasma prior to the onset of dementia symptoms, with specific phosphorylation sites affecting the affinity of binding of the Tau protein to microtubules (Gonzalez-Ortiz et al., 2023). This evidence concerns the gene MAPT and dementia.